Document Detail


Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care.
MedLine Citation:
PMID:  19609624     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Prior studies evaluating racial/ethnic differences in responses to antiretroviral therapy (ART) among HIV-infected patients have not adequately accounted for many potential confounders, and few have included Hispanic patients. OBJECTIVE: To identify racial/ethnic differences in ART adherence, and risk of AIDS and death after ART initiation for HIV patients with similar access to care. DESIGN: Retrospective cohort study. PARTICIPANTS: 4,686 HIV-infected patients (66% White, 20% Black, and 14% Hispanic) initiating ART and who were enrolled in an integrated healthcare system. MEASUREMENTS: Main outcomes evaluated were ART adherence, new AIDS clinical events, and all-cause mortality. The potential confounding effects of demographics, socioeconomic status, ART parameters, HIV disease stage, and other clinical parameters were considered in multivariable models. RESULTS: Adjusted mean adherence levels were higher among White (70.1%; ref) compared with Black (64.2%; P < 0.001) and Hispanic patients (65.2%; P < 0.001). Adjusted hazard ratios (HR) for the risk of new AIDS events (White patients as reference) were 1.3 (P = 0.09) for Black and 0.9 (P = 0.64) for Hispanic patients. The adjusted HR for AIDS comparing Hispanic to Black patients was 0.7 (P = 0.11). Hispanic patients had fewer deaths compared with other racial/ethnic groups, particularly cancer and cardiovascular-related. However, adjusted HRs for death were 1.2 (P = 0.37) and 0.9 (P = 0.62) for Black and Hispanic patients, respectively, compared with White patients and 0.9 (P = 0.63) for Hispanic compared with Black patients. Adjustment for adherence did not change inferences for AIDS or death. CONCLUSIONS: In the setting of similar access to care, we did not observe a disparity for the risk of clinical events for racial/ethnic minorities, despite lower ART adherence.
Authors:
Michael J Silverberg; Wendy Leyden; Charles P Quesenberry; Michael A Horberg
Related Documents :
14712324 - Challenges of adherence management in human immunodeficiency virus pharmacotherapy.
11547704 - How some hiv clinics handle substance abuse.
12564334 - The art of rationing--the need for a new approach to rationing health interventions.
12622674 - Barriers to haart adherence among human immunodeficiency virus-infected adolescents.
7534324 - Hepatitis c virus infection in healthcare workers: risk of exposure and infection.
14529094 - Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2009-07-16
Journal Detail:
Title:  Journal of general internal medicine     Volume:  24     ISSN:  1525-1497     ISO Abbreviation:  J Gen Intern Med     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-14     Completed Date:  2010-04-30     Revised Date:  2010-09-02    
Medline Journal Info:
Nlm Unique ID:  8605834     Medline TA:  J Gen Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1065-72     Citation Subset:  IM    
Affiliation:
Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA. Michael.J.Silverberg@kp.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acquired Immunodeficiency Syndrome / ethnology*,  mortality*,  therapy
Adult
Anti-Retroviral Agents / therapeutic use
Cohort Studies
Continental Population Groups / ethnology*
Ethnic Groups / ethnology*
Female
Follow-Up Studies
HIV Infections / ethnology,  mortality,  therapy
Health Services Accessibility / trends
Healthcare Disparities / trends
Humans
Male
Middle Aged
Mortality / trends
Retrospective Studies
Risk Factors
Treatment Outcome
Grant Support
ID/Acronym/Agency:
K01AI071725/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Anti-Retroviral Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Electronic versus dictated hospital discharge summaries: a randomized controlled trial.
Next Document:  Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale application...